Literature DB >> 10400806

Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes.

R Han1, N M Cladel, C A Reed, X Peng, N D Christensen.   

Abstract

In this study, cottontail rabbit papillomavirus infection of domestic rabbits was used as an animal model to develop papillomavirus early gene-based vaccines. Groups of rabbits were intracutaneously vaccinated with single papillomavirus early genes E1, E2, E6, and E7 or with a combination of these four genes. Only a fraction of rabbits were protected from subsequent viral challenge when vaccinated with the E1 or E6 gene. Viral tumor growth in those rabbits vaccinated with the E1 or E2 gene was suppressed compared to that in controls. In contrast, seven of nine rabbits vaccinated with the combination of the E1, E2, E6, and E7 genes were completely protected against viral challenge. These data indicated that intracutaneous genetic vaccination with the combination of the E1, E2, E6, and E7 genes can be an effective strategy for immunoprophylaxis of papillomavirus infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400806      PMCID: PMC112793     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Shope rabbit papilloma--carcinoma complex. A model system of HPV infections.

Authors:  J W Kreider; G L Bartlett
Journal:  Clin Dermatol       Date:  1985 Oct-Dec       Impact factor: 3.541

2.  Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.

Authors:  R Kirnbauer; L M Chandrachud; B W O'Neil; E R Wagner; G J Grindlay; A Armstrong; G M McGarvie; J T Schiller; D R Lowy; M S Campo
Journal:  Virology       Date:  1996-05-01       Impact factor: 3.616

3.  The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes.

Authors:  N D Christensen; J W Kreider; N C Kan; S L DiAngelo
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

4.  Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product.

Authors:  Y L Lin; L A Borenstein; R Ahmed; F O Wettstein
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits.

Authors:  R Zeltner; L A Borenstein; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

Authors:  D L Montgomery; J W Shiver; K R Leander; H C Perry; A Friedman; D Martinez; J B Ulmer; J J Donnelly; M A Liu
Journal:  DNA Cell Biol       Date:  1993-11       Impact factor: 3.311

7.  Prophylactic and therapeutic vaccination against a mucosal papillomavirus.

Authors:  M S Campo; G J Grindlay; B W O'Neil; L M Chandrachud; G M McGarvie; W F Jarrett
Journal:  J Gen Virol       Date:  1993-06       Impact factor: 3.891

8.  Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas.

Authors:  R Selvakumar; L A Borenstein; Y L Lin; R Ahmed; F O Wettstein
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

9.  Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus.

Authors:  Y L Lin; L A Borenstein; R Selvakumar; R Ahmed; F O Wettstein
Journal:  Virology       Date:  1992-04       Impact factor: 3.616

10.  Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.

Authors:  M H Stoler; C R Rhodes; A Whitbeck; S M Wolinsky; L T Chow; T R Broker
Journal:  Hum Pathol       Date:  1992-02       Impact factor: 3.466

View more
  26 in total

1.  Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits.

Authors:  Jiafen Hu; Nancy Cladel; Karla Balogh; Neil Christensen
Journal:  Vaccine       Date:  2010-03-21       Impact factor: 3.641

Review 2.  [Prophylactic and therapeutic HPV immunization].

Authors:  M Müller; L Gissmann
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

Review 3.  Micro-scale devices for transdermal drug delivery.

Authors:  Anubhav Arora; Mark R Prausnitz; Samir Mitragotri
Journal:  Int J Pharm       Date:  2008-08-30       Impact factor: 5.875

4.  Synonymous codon changes in the oncogenes of the cottontail rabbit papillomavirus lead to increased oncogenicity and immunogenicity of the virus.

Authors:  Nancy M Cladel; Lynn R Budgeon; Jiafen Hu; Karla K Balogh; Neil D Christensen
Journal:  Virology       Date:  2013-02-20       Impact factor: 3.616

5.  Using HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines.

Authors:  Jiafen Hu; Todd D Schell; Xuwen Peng; Nancy M Cladel; Karla K Balogh; Neil D Christensen
Journal:  J Vaccines Vaccin       Date:  2010-08-20

Review 6.  Single-cycle adenovirus vectors in the current vaccine landscape.

Authors:  Michael Barry
Journal:  Expert Rev Vaccines       Date:  2018-01-18       Impact factor: 5.217

7.  Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences.

Authors:  N D Christensen; R Han; N M Cladel; M D Pickel
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 8.  Papillomavirus prophylactic vaccines: established successes, new approaches.

Authors:  M Saveria Campo; Richard B S Roden
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Establishment of a cottontail rabbit papillomavirus/HLA-A2.1 transgenic rabbit model.

Authors:  Jiafen Hu; Xuwen Peng; Lynn R Budgeon; Nancy M Cladel; Karla K Balogh; Neil D Christensen
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

10.  Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines.

Authors:  Sancy A Leachman; Mark Shylankevich; Martin D Slade; Dana Levine; Ranjini K Sundaram; Wei Xiao; Marianne Bryan; Daniel Zelterman; Robert E Tiegelaar; Janet L Brandsma
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.